Apex Healthcare Berhad Beheer

Beheer criteriumcontroles 4/4

De CEO Apex Healthcare Berhad is Kirk Kee, benoemd in May2010, heeft een ambtstermijn van 14.5 jaar. De totale jaarlijkse vergoeding van { bedraagt MYR 283.27K, bestaande uit 18.3% salaris en 81.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.18% van de aandelen van het bedrijf, ter waarde MYR 22.01M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.3 jaar en 6.5 jaar.

Belangrijke informatie

Kirk Kee

Algemeen directeur

RM 283.3k

Totale compensatie

Percentage CEO-salaris	18.3%
Dienstverband CEO	14.5yrs
Eigendom CEO	1.2%
Management gemiddelde ambtstermijn	10.3yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Analyse CEO-vergoeding

Hoe is Kirk Kee's beloning veranderd ten opzichte van Apex Healthcare Berhad's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	RM 89m
Mar 31 2024	n/a	n/a	RM 395m
Dec 31 2023	RM 283k	RM 52k	RM 398m
Sep 30 2023	n/a	n/a	RM 413m
Jun 30 2023	n/a	n/a	RM 415m
Mar 31 2023	n/a	n/a	RM 109m
Dec 31 2022	RM 321k	RM 51k	RM 101m
Sep 30 2022	n/a	n/a	RM 87m
Jun 30 2022	n/a	n/a	RM 74m
Mar 31 2022	n/a	n/a	RM 63m
Dec 31 2021	RM 289k	RM 57k	RM 59m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 53m
Mar 31 2021	n/a	n/a	RM 54m
Dec 31 2020	RM 367k	RM 101k	RM 56m
Sep 30 2020	n/a	n/a	RM 56m
Jun 30 2020	n/a	n/a	RM 56m
Mar 31 2020	n/a	n/a	RM 56m
Dec 31 2019	RM 341k	RM 99k	RM 53m
Sep 30 2019	n/a	n/a	RM 56m
Jun 30 2019	n/a	n/a	RM 56m
Mar 31 2019	n/a	n/a	RM 57m
Dec 31 2018	RM 539k	RM 100k	RM 59m
Sep 30 2018	n/a	n/a	RM 55m
Jun 30 2018	n/a	n/a	RM 51m
Mar 31 2018	n/a	n/a	RM 48m
Dec 31 2017	RM 366k	RM 105k	RM 44m

Compensatie versus markt: De totale vergoeding ($USD 63.51K ) Kirk } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de MY markt ($USD 190.86K ).

Compensatie versus inkomsten: De vergoeding van Kirk is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Kirk Kee (62 yo)

14.5yrs

Tenure

RM 283,273

Compensatie

Dr. Kirk Chin Kee has been the Chief Executive Officer and Chairman of Apex Healthcare Berhad since May 19, 2010 and served as its Managing Director since March 3, 2000. He has been Executive Director of A...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kirk Kee	Chairman & CEO	14.5yrs	RM 283.27k	1.18% MYR 22.0m
Woon Chiew	CFO & Joint Company Secretary	10.3yrs	geen gegevens	geen gegevens
Hing Tan	Chief Operating Officer of Distribution Group	2.7yrs	geen gegevens	geen gegevens
Kien Ch'ng	Chief Operating Officer of Manufacturing Group	9.8yrs	geen gegevens	geen gegevens
Yoke Chan	Joint Company Secretary	10.8yrs	geen gegevens	geen gegevens

10.3yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van AHEALTH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kirk Kee	Chairman & CEO	24.8yrs	RM 283.27k	1.18% MYR 22.0m
Robert Millner	Non-Independent Non-Executive Director	24.8yrs	RM 60.14k	0.061% MYR 1.1m
Khai Leong	Independent Non-Executive Director	3.3yrs	RM 102.00k	0.23% MYR 4.2m
Kirk Kee	Non-Independent Non-Executive Director	8.5yrs	RM 85.00k	geen gegevens
Ah Phang	Independent Non-Executive Director	6.5yrs	RM 102.00k	0.0021% MYR 38.6k
Seng Yap	Independent & Non Executive Director	1.5yrs	RM 69.84k	geen gegevens
Wat Le	Independent & Non-Executive Director	1.5yrs	RM 56.10k	0.0042% MYR 77.5k

6.5yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AHEALTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

Apex Healthcare Berhad Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

New 90-day high: RM3.78

Apex Healthcare Berhad to Be Deleted from Other OTC

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Third quarter 2020 earnings released: EPS RM0.03

Upcoming Dividend of RM0.017 Per Share